John M. Capek, Executive Vice President at ABBOTT LABORATORIES (ABT), sold 100,200 shares at $96.28 ($9.6M) on 2020-04-21, disclosed to the SEC on 2020-04-23.
Open-market sale of $9.6M ABT by Executive Vice President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $95.63 | 31,399 | $3.0M | 31.3% |
| 2 | $95.63 | 31,399 | $3.0M | 31.3% |
| 3 | $96.28 | 18,701 | $1.8M | 18.7% |
| 4 | $96.28 | 18,701 | $1.8M | 18.7% |
| Total | $95.87 avg | 100,200 | $9.6M | 100% |
| Filing → |
| ABT | SELL | 2019-06-21 | $4.0M | — | Filing → |
| ABT | SELL | 2018-07-26 | $4.2M | — | Filing → |
| ABT | SELL | 2017-02-22 | $4.2M | — | Filing → |